Lack of RBC transfusion independence by Day 30 following allogeneic hematopoietic stem cell transplant strongly predicts inferior survival and high non‐relapse mortality in acute myeloid leukemia patients

Ähnliche Einträge

• Comparison of biosimilar filgrastim and originator filgrastim for peripheral blood stem cell mobilization for allogeneic hematopoietic stem cell transplantation
  von: Moazzam Shahzad, et al.
  Veröffentlicht: (2024)
• High CD34‐positive cell dose in matched unrelated donor allogeneic hematopoietic stem cell transplant is not associated with graft‐versus‐host disease or mortality
  von: Zachary M. Avigan, et al.
  Veröffentlicht: (2024)
• Successful treatment pure red cell aplasia after ABO major mismatched allogeneic hematopoietic stem cell transplantation with avatrombopag and low dose rituximab
  von: Junjie Cao, et al.
  Veröffentlicht: (2024)
• Prediction of CD34+ hematopoietic stem cells in healthy allogeneic stem cell donors on the Optia cell separator based on CE2: Which formula is more correlated with actual CD34+?
  von: Sıdıka Gülkan Özkan, et al.
  Veröffentlicht: (2024)
• Cytomegalovirus ‐selected blood components in allogeneic stem cell transplantation: A follow‐up survey of English transplant centre practices
  von: Oliver Firth, et al.
  Veröffentlicht: (2025)